There are 5 clinical trials at NIH that match your
search criteria
Cancer by type/disease: Ovarian
Cancer
A
Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian,
Fallopian, and Peritoneal Cancer
A
Phase II Study of Sorafenib and Bevacizumab in Epithelial Ovarian,
Fallopian, and Peritoneal Cancer Clinical,
Genetic, Behavioral, Laboratory, and Epidemiologic Characterization of
Individuals and Families at High Risk of Breast/Ovarian Cancer
A
Phase I Study With an Expansion Cohort of the PARP Inhibitor AZD2281
(KU-0059436) Combined With Carboplatin in Breast and Ovarian Cancer in
BRCA 1/2 Mutation Carriers, Familial Breast and Ovarian Cancer, and
Sporadic Triple Negative Breast Cancer and Ovarian Cancer
A
Phase I, Open-Label Study of MEDI-547 to Evaluate the Safety,
Tolerability, Pharmacokinetics, and Biologic Activity of Intravenous
Administration in Subjects With Refractory Solid Tumors Associated With
EphA2 Expression
A
Phase I Study of Dasatinib in Combination With Bevacizumab in Advanced
Solid Tumors
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.